KIR2DL3⁺NKG2A⁻ natural killer cells are associated with protection from productive hepatitis C virus infection in people who inject drugs. (Q42221479)
Jump to navigation
Jump to search
scientific article published on 26 April 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | KIR2DL3⁺NKG2A⁻ natural killer cells are associated with protection from productive hepatitis C virus infection in people who inject drugs. |
scientific article published on 26 April 2014 |
Statements
KIR2DL3⁺NKG2A⁻ natural killer cells are associated with protection from productive hepatitis C virus infection in people who inject drugs (English)
Christine Thoens
Martin Trippler
Holger Siemann
Melanie Lutterbeck
Jörg Schlaak
Falko M Heinemann
Andreas Heinold
Jacob Nattermann
Norbert Scherbaum